Adaptive Biotechnologies Corporation Stock
Stocks
ADPT
US00650F1093
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 26.64 USD | -5.43% |
|
+4.43% | +64.04% |
| Market Cap | 4.25B 3.81B 3.5B 3.17B 5.93B 404B 6.04B 41.77B 16.77B 212B 15.96B 15.62B 670B | P/E 2026 * |
-49.4x | P/E 2027 * | -154x |
|---|---|---|---|---|---|
| Enterprise Value | 3.96B 3.55B 3.27B 2.96B 5.53B 376B 5.64B 38.95B 15.63B 198B 14.88B 14.56B 624B | EV / Sales 2026 * |
13.5x | EV / Sales 2027 * | 10.9x |
| Free-Float |
97.95% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ADPT | Delayed | |
CBOE
| ADPT | Real-time | |
|
Deutsche Boerse AG
| 1HM | Delayed | |
|
Boerse Muenchen
| 1HM | Real-time | |
|
Tradegate
| 1HM | Real-time | |
|
Börse Stuttgart
| 1HM | Delayed |
Last Transcript: Adaptive Biotechnologies Corporation
| 1 day | -5.43% | ||
| 1 week | +4.43% | ||
| Current month | -7.82% | ||
| 1 month | -7.82% | ||
| 3 months | +10.17% | ||
| 6 months | +88.94% | ||
| Current year | +64.04% |
| 1 week | 25.24 |  | 29.05 |
| 1 month | 23.82 | | 30.74 |
| Current year | 12 | | 30.74 |
| 1 year | 12 | | 30.74 |
| 3 years | 2.28 | | 30.74 |
| 5 years | 2.28 | | 37.55 |
| 10 years | 2.28 | | 71.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chad Robins
CEO | Chief Executive Officer | 51 | 2009-09-07 |
Kyle Piskel
DFI | Director of Finance/CFO | 42 | 2024-04-07 |
Julie Rubinstein
PSD | President | 54 | 2018-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Chad Robins
CHM | Chairman | 51 | - |
Robert Hershberg
BRD | Director/Board Member | 63 | 2013-01-31 |
Peter Neupert
BRD | Director/Board Member | 70 | 2013-11-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/16/26 | Exercice | Chairperson | 35,643 | 0.0223% | ||
| 10/13/26 | Exercice | Chairperson | 35,643 | 0.0223% | ||
| 10/8/26 | Exercice | Chairperson | 35,643 | 0.0223% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.43% | +4.43% | +57.54% | +515.24% | 4.25B | |
| -0.62% | -1.87% | +46.31% | +56.99% | 63.77B | |
| +0.35% | +3.20% | +14.92% | +84.55% | 56.37B | |
| +0.53% | +1.96% | +15.37% | +106.81% | 54.62B | |
| -2.81% | -4.31% | +23.50% | +50.90% | 44.06B | |
| -0.33% | -1.93% | +20.15% | +98.45% | 42.11B | |
| +0.55% | +2.31% | +224.97% | +942.56% | 41B | |
| +3.27% | +47.96% | +112.67% | +96.48% | 34.92B | |
| +1.22% | -1.44% | +14.89% | +47.15% | 32.82B | |
| +0.89% | +20.55% | -42.03% | +373.03% | 24.7B | |
| Average | -0.24% | +7.23% | +48.83% | +237.21% | 39.86B | |
| Weighted average by Cap. | +0.12% | +5.43% | +48.60% | +189.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 293M 263M 242M 219M 409M 27.84B 417M 2.88B 1.16B 14.65B 1.1B 1.08B 46.19B | 360M 323M 297M 269M 503M 34.2B 512M 3.54B 1.42B 17.99B 1.35B 1.32B 56.73B |
| Net income | -85.03M -76.15M -70.05M -63.47M -119M -8.07B -121M -835M -335M -4.25B -319M -312M -13.39B | -27.23M -24.39M -22.43M -20.33M -38M -2.59B -38.71M -268M -107M -1.36B -102M -100M -4.29B |
| Net Debt | -287M -257M -237M -214M -401M -27.27B -408M -2.82B -1.13B -14.35B -1.08B -1.05B -45.24B | -331M -296M -273M -247M -462M -31.41B -470M -3.25B -1.3B -16.52B -1.24B -1.22B -52.11B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | US$26.64 | -5.43% | 4,256,500 |
| 26-10-29 | US$28.17 | -0.70% | 2,588,870 |
| 26-10-28 | US$28.37 | +2.57% | 2,317,531 |
| 26-10-27 | US$27.66 | +5.29% | 1,535,602 |
| 26-10-26 | US$26.27 | +2.98% | 1,164,557 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ADPT Stock
Select your edition
All financial news and data tailored to specific country editions
